Silhouette of a person with a colourful brain

Emyria opens second Empax centre in Perth to meet mental health demand

Emyria Ltd has launched a second Empax clinic in Western Australia, aiming to support patients with…
3D illustration of the human brain

Argenica doses final patients in acute ischaemic stroke trial

Argenica Therapeutics Ltd has taken an important step in completion of its Phase 2 trial to…
A person counting money

Recce to raise $15.8M in trial funds through placement, entitlement offer

Recce Pharmaceuticals Ltd plans to raise $5 million through a Placement to a private investor in…
MRI of brain injury

Study finds Nyrada’s lead drug can prevent secondary brain injury

Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding…
Human brain neurons

Neurizon finds positive results for lead drug in 3D brain model study

Neurizon Therapeutics Ltd has completed a study together with Tessara Therapeutics on the impact of NUZ-001…
Image of drugs on a platform

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to…
Dices forming the acronym ALS

‘Maximising the potential’: Neurizon prepares for HEALEY study of ALS

Neurizon Therapeutics Ltd has provided an update to its preparations for the HEALEY Platform Trial to…
Imaging machine for the brain

Actinogen reports busy 6 months as development of Xanamem molecule ramps up

Actinogen Medical Ltd said it had pared back net losses in the 6 months to December…
Image of the Nasodine nasal spray product

The world needs Nasodine: Here’s why…

With the ongoing parade of pandemic threats, a tappable market for Firebrick Pharma's Nasodine isn’t going…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Looking ahead to a year of intriguing investment opportunities

The New Year brings renewed energy, exciting opportunities, and the promise of growth. But will the…